These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 20585874

  • 1. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?
    Baratti D, Pennacchioli E, Kusamura S, Fiore M, Balestra MR, Colombo C, Mingrone E, Gronchi A, Deraco M.
    Ann Surg Oncol; 2010 Dec; 17(12):3220-8. PubMed ID: 20585874
    [Abstract] [Full Text] [Related]

  • 2. Aggressive locoregional management of recurrent peritoneal sarcomatosis.
    Baumgartner JM, Ahrendt SA, Pingpank JF, Holtzman MP, Ramalingam L, Jones HL, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA.
    J Surg Oncol; 2013 Mar; 107(4):329-34. PubMed ID: 23386388
    [Abstract] [Full Text] [Related]

  • 3. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal sarcomatosis.
    Salti GI, Ailabouni L, Undevia S.
    Ann Surg Oncol; 2012 May; 19(5):1410-5. PubMed ID: 22302269
    [Abstract] [Full Text] [Related]

  • 4. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: postoperative and long-term results.
    Golse N, Bakrin N, Passot G, Mohamed F, Vaudoyer D, Gilly FN, Glehen O, Cotte E.
    J Surg Oncol; 2012 Aug 01; 106(2):197-203. PubMed ID: 22331814
    [Abstract] [Full Text] [Related]

  • 5. Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases.
    Chua TC, Quinn LE, Zhao J, Morris DL.
    J Surg Oncol; 2013 Aug 01; 108(2):81-8. PubMed ID: 23737041
    [Abstract] [Full Text] [Related]

  • 6. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Dileo P, Laterza B, Deraco M.
    Ann Surg Oncol; 2009 Feb 01; 16(2):463-72. PubMed ID: 19082859
    [Abstract] [Full Text] [Related]

  • 7. The treatment of peritoneal carcinomatosis of colorectal cancer with complete cytoreductive surgery and hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) with oxaliplatin: a Belgian multicentre prospective phase II clinical study.
    Hompes D, D'Hoore A, Van Cutsem E, Fieuws S, Ceelen W, Peeters M, Van der Speeten K, Bertrand C, Legendre H, Kerger J.
    Ann Surg Oncol; 2012 Jul 01; 19(7):2186-94. PubMed ID: 22395983
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.
    Ann Ital Chir; 2008 Jul 01; 79(4):231-9. PubMed ID: 19093624
    [Abstract] [Full Text] [Related]

  • 9. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M, Nonaka D, Baratti D, Casali P, Rosai J, Younan R, Salvatore A, Cabras Ad AD, Kusamura S.
    Ann Surg Oncol; 2006 Feb 01; 13(2):229-37. PubMed ID: 16444562
    [Abstract] [Full Text] [Related]

  • 10. Hepatobiliary procedures in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Glockzin G, Renner P, Popp FC, Dahlke MH, von Breitenbuch P, Schlitt HJ, Piso P.
    Ann Surg Oncol; 2011 Apr 01; 18(4):1052-9. PubMed ID: 21046262
    [Abstract] [Full Text] [Related]

  • 11. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Cabras AD, Bertulli R, Hutanu I, Deraco M.
    Eur J Cancer; 2013 Oct 01; 49(15):3140-8. PubMed ID: 23831335
    [Abstract] [Full Text] [Related]

  • 12. Cytoreductive Surgery and HIPEC as a Treatment Option for Laparoscopic Resection of Uterine Leiomyosarcoma with Morcellation: Early Results.
    Sugarbaker P, Ihemelandu C, Bijelic L.
    Ann Surg Oncol; 2016 May 01; 23(5):1501-7. PubMed ID: 26545375
    [Abstract] [Full Text] [Related]

  • 13. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Oliva GD, Laterza B, Deraco M.
    Ann Surg Oncol; 2007 Oct 01; 14(10):2790-7. PubMed ID: 17661150
    [Abstract] [Full Text] [Related]

  • 14. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
    Yang XJ, Li Y, al-shammaa Hassan AH, Yang GL, Liu SY, Lu YL, Zhang JW, Yonemura Y.
    Ann Surg Oncol; 2009 Feb 01; 16(2):345-51. PubMed ID: 19018599
    [Abstract] [Full Text] [Related]

  • 15. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
    Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
    Ann Surg Oncol; 2008 Sep 01; 15(9):2426-32. PubMed ID: 18521686
    [Abstract] [Full Text] [Related]

  • 16. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
    Canbay E, Mizumoto A, Ichinose M, Ishibashi H, Sako S, Hirano M, Takao N, Yonemura Y.
    Ann Surg Oncol; 2014 Apr 01; 21(4):1147-52. PubMed ID: 24356799
    [Abstract] [Full Text] [Related]

  • 17. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):207-12. PubMed ID: 16767933
    [Abstract] [Full Text] [Related]

  • 18. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients.
    Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M, Cavaliere F, Kusamura S, Gronchi A, Lise M.
    Cancer; 2004 May 01; 100(9):1943-50. PubMed ID: 15112276
    [Abstract] [Full Text] [Related]

  • 19. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination.
    Jimenez WA, Sardi A, Nieroda C, Gushchin V.
    Am J Obstet Gynecol; 2014 Mar 01; 210(3):259.e1-8. PubMed ID: 24211479
    [Abstract] [Full Text] [Related]

  • 20. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
    Rossi CR, Foletto M, Mocellin S, Pilati P, De SM, Deraco M, Cavaliere F, Palatini P, Guasti F, Scalerta R, Lise M.
    Cancer; 2002 Jan 15; 94(2):492-9. PubMed ID: 11900234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.